New clinical trial analyses predict response to benralizumab by patients with COPD
Chronic obstructive pulmonary disease, or COPD, is the third leading cause of death in the U.S., according to the American Lung Association. More than 15.3 million people in this country suffer from it and they often experience ...
Sep 30, 2019
0
7
